Key result
The administration of flecainide successfully eliminated episodes of catecholaminergic polymorphic ventricular tachycardia and appropriate ICD shocks for 24 months in a patient refractory to beta-blockers.
Why the study?
CPVT is a potentially fatal hereditary arrhythmogenic disease in children with structurally normal hearts that is often underdiagnosed due to diagnostic difficulties and misclassification as epilepsy or vasovagal syncope.
Case Report (n=1)
No
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a severe cardiac arrhythmogenic hereditary illness, which affects children and young adults with a structurally healthy heart. Its prevalence is of one case in 10 thousand inhabitants. It is a potentially fatal illness, part of the differential diagnosis of syncope in children. The present study has the purpose of relating the case of a child that, during the investigation of convulsive syncope, presented sudden death aborted due to CPVT and to describe the diagnosis difficulties of the case, comparing with data from the literature
No takes yet. Share an insight, caveat, or question.
Porto et al. (2019) conducted a case report in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) (n=1). Flecainide was evaluated on Recurrence of CPVT episodes and appropriate ICD shocks. The administration of flecainide successfully eliminated episodes of catecholaminergic polymorphic ventricular tachycardia and appropriate ICD shocks for 24 months in a patient refractory to beta-blockers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: